Antitumour necrosis factor alpha (anti-TNFα) agents include infliximab, adalimumab, golimumab, AVX-470 and OPRX-106. Janus kinase (JAK) inhibitors: tofacitinib, filgotinib and upadacitinib.

Drug-induced liver injury (DILI) is a significant concern in clinical practice, arising from medications, herbs, and dietary ...

However, how Mtb manipulates host molecular switches of cell death pathways to reprogram cell death modalities and drive tuberculosis pathogenesis remains poorly understood. In a study published ...